CytoMed Therapeutics Limited Ordinary Shares Long-term Investment Intensity
CytoMed Therapeutics Limited Ordinary Shares long-term investment intensity. CytoMed Therapeutics Limited Ordinary Shares (GDTC) has a Long-term Investment Intensity of 0.2% as of December 2025. Long-term investments of $18.21K represent 0.2% of total assets of $7.98 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read GDTC total liabilities for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of CytoMed Therapeutics Limited Ordinary Shares (2021–2025)
Long-term investment intensity of CytoMed Therapeutics Limited Ordinary Shares from 2021 to 2025. This chart shows how CytoMed Therapeutics Limited Ordinary Shares's Long-term Investment Intensity has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the intensity stands at 0.2%, reflecting long-term investments of $18.21K against total assets of $7.98 Million USD.
CytoMed Therapeutics Limited Ordinary Shares Long-term Investment Intensity by Year (2021–2025)
CytoMed Therapeutics Limited Ordinary Shares long-term investment intensity by year from 2021 to 2025. The table below presents the year-by-year Long-term Investment Intensity for CytoMed Therapeutics Limited Ordinary Shares from 2021 to 2025, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see CytoMed Therapeutics Limited Ordinary Sh assets under control.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 0.2% | $18.21K | $7.98 Million | ▼ -2.0 pp |
| 2024 | 2.2% | $220.95K | $10.07 Million | ▲ +0.6 pp |
| 2023 | 1.6% | $195.07K | $12.40 Million | ▼ -3.0 pp |
| 2022 | 4.6% | $239.42K | $5.25 Million | ▲ +0.1 pp |
| 2021 | 4.5% | $272.97K | $6.10 Million | — |